| PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections (NCT05355350) | Rambam Health Care Campus | 2022-07-01 |
| Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. (NCT04276480) | University Hospital, Bordeaux | 2022-02-16 |
| Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic (NCT05055479) | Centre Hospitalier Universitaire, Amiens | 2021-08-01 |
| Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae (NCT04903886) | University Hospital, Brest | 2021-06-01 |
| Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC (NCT04836208) | Institut Pasteur | 2021-04-30 |
| Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics (NCT03967301) | Hospital Italiano de Buenos Aires | 2019-10-01 |
| ANTIBIOTIC-RESISTANT ENTEROBACTERALES BLOODSTREAM INFECTIONS AND RISK FACTORS IN PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT (NCT07172932) | Ankara City Hospital Bilkent | 2019-09-01 |
| Pilot Study Using Oral Capsule FMT to Decolonize GI CRE (NCT03527056) | University of California, Los Angeles | 2019-06-01 |
| Community-associated Highly-Resistant Enterobacterales (NCT03924934) | University of North Carolina, Chapel Hill | 2019-05-01 |
| Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (NCT03891433) | Universidad del Norte | 2019-04-01 |
| Prevalence of ESBL and CPE in French Nursing Homes (NCT03401242) | Nantes University Hospital | 2018-10-03 |
| The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers (NCT03411590) | FrieslandCampina WAMCO Nigeria PLC | 2018-02-05 |
| Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit (NCT04528043) | Central Hospital, Nancy, France | 2017-04-01 |
| Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities (NCT03477084) | Centre Hospitalier Universitaire de Besancon | 2017-03-01 |
| Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae (NCT02795949) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2016-10-01 |
| Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood (NCT02482051) | Denver Health and Hospital Authority | 2015-07-01 |
| 18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection (NCT02450942) | Peking Union Medical College Hospital | 2015-01-01 |
| Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae (NCT02400268) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2014-09-01 |
| Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study (NCT00826670) | University Hospital, Geneva | 2009-06-01 |
| The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children (NCT00894036) | University Hospital, Geneva | 2008-07-01 |
| Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms (NCT00573521) | University of Pittsburgh | 2007-11-01 |
| Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli (NCT00573235) | University of Pittsburgh | 2007-10-01 |
| Infections Caused by ESbL-Producing Enterobacteriaceae in Italy (NCT00404625) | University of Siena | 2006-10-01 |